Molecular Biology Consortium Inc
- Assets
- $1.0m
- Revenue
- $483.0k
- Investments
- $0.0
- Employees
- 3
- Location
- Naperville, IL
- Founding
- 02/2002
- Data as of
- 06/2023
- EIN
- 36-4334866
Organization Overview
Molecular Biology Consortium Inc is located in Naperville, IL. The organization was established in 2002. According to its NTEE Classification (M03) the organization is classified as: Professional Societies & Associations, under the broad grouping of Public Safety, Disaster Preparedness & Relief and related organizations. As of 06/2023, Molecular Biology Consortium Inc employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Molecular Biology Consortium Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2023, Molecular Biology Consortium Inc generated $483.0k in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 0.9% each year. All expenses for the organization totaled $452.3k during the year ending 06/2023. While expenses have increased by 1.9% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
SCIENTIFIC RESEARCH AND TEACHING USING X-RAY CRYSTALLOGRAPHY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DR. JAY NIX IS THE BEAMLINE DIRECTOR FOR THE MOLECULAR BIOLOGY CONSORTIUM. THROUGH THE SERVICE CRYSTALLOGRAHY PROGRAM, DR. NIX INSTITUTED, MEMBERS HAVE MADE IMPORTANT ADVANCES IN UNDERSTANDING THE BIOCHEMISTRY AND MOLECULAR BIOLOGY OF HUMAN DISEASES AND INFECTION AT BEAMLINE 4.2.2 INCLUDING WORK ON CHIKUNGUNGYA VIRUS, ZIKA VIRUS, AND ANTIBODIES BOUND TO THE SARS-COV-2 SPIKE PROTEIN (RESULTING IN THE MAB TREATMENT SOTROVIMAB). MOLECULAR BIOLOGY CONSORTIUM'S BEAMLINE 4.2.2 WAS THE FIRST AT THE ADVANCED LIGHT SOURCE (ALS) TO PROVIDE REMOTE OPERATIONS TO THEIR RESEARCHERS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Philip Matsumura Chairman | OfficerTrustee | 4 | $11,250 |
John Kappler Vice Chairman (thru 06/23) | OfficerTrustee | 1 | $0 |
Gerald Hazelbauer Secretary/treasurer | OfficerTrustee | 1 | $0 |
Mair Churchill Director | Trustee | 1 | $0 |
Daved Fremont Director | Trustee | 1 | $0 |
Giovanni Gonzalez-Gutierrez Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $156,374 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $156,374 |
| Total Program Service Revenue | $316,600 |
| Investment income | $9,977 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $482,951 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $314,560 |
| Compensation of current officers, directors, key employees. | $4,500 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $30,270 |
| Pension plan accruals and contributions | $2,239 |
| Other employee benefits | $3,391 |
| Payroll taxes | $18,070 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $47,392 |
| Advertising and promotion | $0 |
| Office expenses | $13,947 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $5,122 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $6,723 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,351 |
| Insurance | $8,367 |
| All other expenses | $861 |
| Total functional expenses | $452,293 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $973,964 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $38,539 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $3,106 |
| Net Land, buildings, and equipment | $3,028 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $1,018,637 |
| Accounts payable and accrued expenses | $75,065 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $75,065 |
| Net assets without donor restrictions | $943,572 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,018,637 |